Pfizer front runner to clinch Strides Arcolab’s specialty biz for $1.7B

Premium

Global pharmaceutical manufacturer Pfizer is in advanced talks with Strides Arcolab to buy its specialty business housing injectable drug unit for $1.7 billion (Rs 9,460 crore), three people with knowledge of the development told VCCircle. This would be the third largest M&A deal in the pharmaceutical sector in India, behind ......